Pediatrix Medical (MD) Net Income towards Common Stockholders (2009 - 2026)

Pediatrix Medical (MD) has 17 years of Net Income towards Common Stockholders data on file, last reported at $29.6 million in Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at $29.6 million, up 42.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $183.8 million (up 317.47% YoY), and the FY2025 annual result was $175.0 million, changed N/A from the prior year.
• Net Income towards Common Stockholders slipped to $29.6 million in Q1 2026 per MD's latest filing, from $43.3 million in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $71.7 million in Q3 2025 and troughed at -$153.0 million in Q2 2024.
• A 4-year average of $8.2 million and a median of $19.4 million in 2024 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2022 and 2025: Net Income towards Common Stockholders slumped 179.61% in 2022, then surged 413.93% in 2025.
• A 4-year view of Net Income towards Common Stockholders shows it stood at $5.7 million in 2022, then surged by 400.34% to $28.3 million in 2024, then surged by 52.91% to $43.3 million in 2025, then tumbled by 31.7% to $29.6 million in 2026.
• Business Quant data shows MD's Net Income towards Common Stockholders at $29.6 million in Q1 2026, $43.3 million in Q4 2025, and $71.7 million in Q3 2025.